Key result
Elevated high-sensitivity cardiac troponin T > 100 µg/l was associated with a significantly higher 3-month mortality (HR 10.523) in patients seeking emergency care for acute dyspnea without myocardial infarction.
Why the study?
Elevated cardiac troponin T occurs in ED patients without MI, but its clinical importance remains unclear, particularly in patients presenting with acute dyspnea and high cardiovascular comorbidity.
Does elevated hs-cTnT predict 3-month mortality in patients presenting to the emergency department with acute dyspnea without acute myocardial infarction?
Cohort (n=1,001)
No
Does elevated hs-cTnT predict 3-month mortality in patients presenting to the emergency department with acute dyspnea without acute myocardial infarction?
Hazard Ratio: 10.523 (95% CI 4.465–24.803)
Absolute Event Rate: 41.4% vs 2.2%
p-value: p=<0.001
Elevated high-sensitivity cardiac troponin T in patients presenting to the emergency department with acute dyspnea without acute myocardial infarction is a strong, independent predictor of 3-month mortality.
Elevated hs-cTnT may aid mortality risk stratification in ED dyspnea without MI; leaves open need for prospective validation before guiding care.
BACKGROUND: Elevated levels of cardiac troponin T has been observed in patients seeking care at the emergency department (ED) presenting with chest pain but without myocardial infarction (MI). The clinical importance of this observation remains, however, still unclear. Our main aim was to study the role of cardiac troponin T in patients admitted to the emergency department with acute dyspnea, a group of patients with a high cardiovascular comorbidity, but no primary acute MI. POPULATION AND METHODS: Patients from the age of 18 seeking care at the ED for dyspnea, without an acute cardiac syndrome, and with a recorded assessment of high-sensitivity cardiac troponin T (hs-cTnT), were included (n = 1001). Patients were categorized into 3 groups by hs-cTnT level, i.e. <15, 15-100 and > 100 µg/l. Cox regression with Hazard Ratios (HRs) and 95% Confidence Intervals (CI) for 3-months mortality was performed, with adjustment for sex, age, respiratory frequency, saturation, CHF, renal disease, and BMI. RESULTS: Fully adjusted HRs (95% CI) for 3-month mortality, with hs-cTnT < 15 µg/l as reference level, showed for hs-cTnT 15-100 a HR of 3.682 (1.729-7.844), and for hs-cTnT > 100 a HR of 10.523 (4.465-24.803). CONCLUSION: Elevated hs-cTnT seems to be a relevant marker of poor prognosis in patients with acute dyspnea without MI and warrants further validation and clinical testing.
No takes yet. Share an insight, caveat, or question.
Wessman et al. (2023) conducted a cohort in Acute dyspnea without acute cardiac syndrome (n=1,001). Elevated high-sensitivity cardiac troponin T (hs-cTnT > 100 µg/l) vs. hs-cTnT < 15 µg/l was evaluated on 3-month mortality (HR 10.523, 95% CI 4.465-24.803, p=<0.001). Elevated high-sensitivity cardiac troponin T > 100 µg/l was associated with a significantly higher 3-month mortality (HR 10.523) in patients seeking emergency care for acute dyspnea without myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: